Towards Personalized Management of Ovarian Cancer

Despite advances in surgery and chemotherapy, the overall outcomes for patients with advanced ovarian cancer remain poor. Although initial response rates to platinum-based chemotherapy is about 60–80%, most patients will have recurrence and succumb to the disease. However, a DNA repair–directed prec...

Descripción completa

Detalles Bibliográficos
Autores principales: Algethami, Mashael, Kulkarni, Sanat, Sadiq, Maaz T, Tang, Hiu K C, Brownlie, Juliette, Jeyapalan, Jennie N, Mongan, Nigel P, Rakha, Emad A, Madhusudan, Srinivasan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762171/
https://www.ncbi.nlm.nih.gov/pubmed/36545222
http://dx.doi.org/10.2147/CMAR.S366681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762171/
https://www.ncbi.nlm.nih.gov/pubmed/36545222
http://dx.doi.org/10.2147/CMAR.S366681

Ejemplares similares